127 related articles for article (PubMed ID: 7127663)
1. Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.
Devleeschouwer N; Leclercq G; Danguy A; Atassi G
Cancer Chemother Pharmacol; 1982; 8(3):315-6. PubMed ID: 7127663
[No Abstract] [Full Text] [Related]
2. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
3. Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
Rahman A; Fumagalli A; Barbieri B; Schein PS; Casazza AM
Cancer Chemother Pharmacol; 1986; 16(1):22-7. PubMed ID: 3940217
[TBL] [Abstract][Full Text] [Related]
4. Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.
Sava G; Giraldi T; Bartoli-Klugmann F; Decorti G; Mallardi F
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):287-9. PubMed ID: 6538492
[No Abstract] [Full Text] [Related]
5. Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
Johnson RK; Howard WS
Eur J Cancer Clin Oncol; 1982 May; 18(5):479-87. PubMed ID: 6956514
[No Abstract] [Full Text] [Related]
6. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
Narita T; Yaguchi S; Komatsu T; Takase M; Hoshino A; Inaba M; Tsukagoshi S
Cancer Chemother Pharmacol; 1990; 26(3):193-7. PubMed ID: 2357766
[TBL] [Abstract][Full Text] [Related]
7. Activity of a novel carotenoid analog, 4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaen -1,18- diyl) bis(1-ethylpyridinium) dibromide (Y-18598) on mouse leukemia P388.
Okumoto T; Morita N; Nakamura I; Konishi M; Yamaguchi M
J Cancer Res Clin Oncol; 1985; 109(3):257-9. PubMed ID: 3839242
[TBL] [Abstract][Full Text] [Related]
8. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
Marsh JC; Shoemaker RH; Suffness M
Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
[TBL] [Abstract][Full Text] [Related]
9. [Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
Shestova OL; Ogloblina TA; Litinskaia LL
Eksp Onkol; 1990; 12(3):61-2. PubMed ID: 2344828
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileukemic activity of fluorinated analogues of 2,3-dihydro-5-phenyl-6,7-bis(hydroxymethyl)-1H-pyrrolizine biscarbamate.
Anderson WK; McPherson HL
J Med Chem; 1982 Jan; 25(1):84-6. PubMed ID: 7086826
[No Abstract] [Full Text] [Related]
11. Preclinical antitumor activity of batracylin (NSC 320846).
Plowman J; Paull KD; Atassi G; Harrison SD; Dykes DJ; Kabbe HJ; Narayanan VL; Yoder OC
Invest New Drugs; 1988 Sep; 6(3):147-53. PubMed ID: 3192381
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
Lin TS; Fischer PH; Prusoff WH
Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
[No Abstract] [Full Text] [Related]
13. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
Lee SH; Thomas LK; Unger FM; Christian R; Sartorelli AC
Int J Cancer; 1981 May; 27(5):703-8. PubMed ID: 6974703
[No Abstract] [Full Text] [Related]
14. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
Petru E; Berger MR; Zeller WJ; Kaufmann M
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940
[TBL] [Abstract][Full Text] [Related]
15. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
Köpf-Maier P; Wagner W; Hesse B; Köpf H
Eur J Cancer (1965); 1981 Jun; 17(6):665-9. PubMed ID: 7308264
[No Abstract] [Full Text] [Related]
16. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
[TBL] [Abstract][Full Text] [Related]
18. Therapy of P388 leukemia with benzaldehyde.
Balázová E; Koza I
Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
[TBL] [Abstract][Full Text] [Related]
19. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
[No Abstract] [Full Text] [Related]
20. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
Chiuten DF; Muggia FM; Johnson RK
Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
